A team from the Research Institute of the McGill University Health Center (The Institute), led by Jean-Jacques Lebrun, Ph.D., ...

Have we passed the peak of biotech layoffs? It’s too early to say for certain—but an intriguing story is playing out in the ...

"Compared with plasmid DNA, synthetic DNA offers advantages in purity, safety and scalability. As development pipelines ...

Most people have never heard of α-Klotho. But the scientific community has been quietly obsessed with it since 1997, when ...

In this episode of Humans of Iowa State, Onyeka Onyenemezu, a graduate student in chemical engineering, shares her insight as ...

But it has proved in the past decade that it can be an innovation powerhouse. China is now far ahead of the United States in manufacturing and deploying advanced technologies such as electric vehicles ...

Synthego, a pioneering leader in genome engineering solutions, today announced that the Supreme Court of the United States has denied a petition for a writ of certiorari from Agilent Technologies, Inc ...

The gene therapy regimen seems to be working wonders, including restoring nearly all hearing to a seven-year-old patient ...

A phase 1/2 trial of a novel viral vector gene therapy in adults with type 1 diabetes is scheduled to begin this year.

Discover how TP53 mutations in adult leukaemia impact treatment outcomes and potential strategies for improved patient care.

News Mirrored molecules target disordered proteins in Alzheimer’s disease. 2026-03-31T09:28:00. Researchers at Kobe University have developed a novel approach to Alzheimer’s d ...